Efficacy and Safety of Current Drug Therapies for Invasive Aspergillosis
Efficacy and Safety of Current Drug Therapies for Invasive Aspergillosis
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Invasive aspergillosis (IA) is a potentially lethal infection that affects mostly immunocompromised patients. The therapeutic goals are to restore leucocyte function and to reduce the fungal burden by effective antifungal agents and, contingently, by surgery. Several drugs for the treatment of IA are currently licensed. The longest known among them...
Alternative Titles
Full title
Efficacy and Safety of Current Drug Therapies for Invasive Aspergillosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1159_000331860
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1159_000331860
Other Identifiers
ISSN
0031-7012
E-ISSN
1423-0313
DOI
10.1159/000331860
